Skip to content

Early prophylactic antibiotics in the treatment of hyperlipidemic severe acute pancreatitis: a multicenter prospective randomized controlled study

Early prophylactic antibiotics in the treatment of hyperlipidemic severe acute pancreatitis: a multicenter prospective randomized controlled study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050724
Enrollment
Unknown
Registered
2021-09-03
Start date
2021-09-20
Completion date
Unknown
Last updated
2022-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperlipidemic severe acute pancreatitis

Interventions

experimental group:72 hours after admission,patients were given 0.4g moxifloxacin intravenously once a day for 5 days.
control group:Give routine treatment

Sponsors

The Second Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 70 years; 2. On the basis of meeting the diagnostic criteria of AP in the 2013 Atlanta Revised Criteria, if the patient meets the following conditions, the diagnosis of HTG-AP is made: blood TG >= 11.30 mmol/L; or blood TG is between 5.65 and 11.30 mmol/L , and the serum was chyle-shaped; 3. Modified Marshall score of organ failure >= 2 points, or enhanced CT examination showed that the area of pancreatic necrosis >= 30%; 4. The onset time was less than 48 hours from admission.

Exclusion criteria

Exclusion criteria: 1. Biliary pancreatitis, alcoholic pancreatitis and other types of pancreatitis; 2. Previous organ dysfunction or autoimmune diseases such as liver and kidney; 3. Prophylactic use of any antibiotics after the onset of the disease; 4. Antibiotics are required for infections in the lungs, bloodstream, and urinary system at the time of onset.

Design outcomes

Primary

MeasureTime frame
Incidence of pancreatic / peripancreatic necrosis infection;Occurrence of multiple organ failure;

Secondary

MeasureTime frame
Length of stay, length of stay in ICU and hospitalization cost;

Countries

China

Contacts

Public ContactSun Yun

The Second Affiliated Hospital of Anhui Medical University

2247619909@qq.com+86 13083400880

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026